Replimune (REPL) Equity Average (2018 - 2025)

Replimune has disclosed Equity Average across 8 years of filings, most recently posting $236.9 million for Q4 2025.

• Equity Average for Q4 2025 came in at $236.9 million, down 45.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $236.9 million (down 45.14% YoY), and the FY2025 annual result was $395.2 million, down 15.0% from the prior year.
• Equity Average came in at $236.9 million for Q4 2025 at Replimune, down from $300.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $575.3 million in Q1 2023 to a low of $236.9 million in Q4 2025.
• The 5-year median for Equity Average is $437.6 million (2023), against an average of $433.7 million.
• Across the five-year window, Equity Average jumped 166.19% in 2021 and plunged 45.14% in 2025, its largest moves.
• Replimune's Equity Average stood at $447.5 million in 2021, then gained by 9.44% to $489.7 million in 2022, then slipped by 9.47% to $443.4 million in 2023, then fell by 2.58% to $431.9 million in 2024, then slumped by 45.14% to $236.9 million in 2025.
• The last three Equity Average figures came in at $236.9 million (Q4 2025), $300.0 million (Q3 2025), and $376.3 million (Q2 2025), per Business Quant data.